Bibliography
Found 1068 results
Brain gene expression studies in dementia: Drug abuse, HIV, and amyloid. In: 3rd International Differential Gene Expression Symposium. 3rd International Differential Gene Expression Symposium. Vanderbilt University School of Medicine; 2002.
. A candidate gene study of HIV-dementia in the National NeuroAIDS Tissue Consortium. In: 2nd Annual AIDS Research Symposium at UCLA. 2nd Annual AIDS Research Symposium at UCLA. ; 2009.
. CCL3L1 gene copy number in the Northeast AIDS Dementia (NEAD) Cohort and the National NeuroAIDS Tissue Consortium (NNTC). In: Conference on Retroviruses. Conference on Retroviruses. ; 2009.
. CD68 and HIV P24 expression in CNS and visceral tissues in HIV associated PML. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. pp. 99-100.
. CD68 positive cells in the CNS of HIV1/PML patients express CD16 and KI67 but few cells express CD14. Evidence for expansion of the resident microglial population. In: Journal of NeuroVirology. Vol. 10. Journal of NeuroVirology. ; 2004. pp. 66-67.
. Central Viral Loads and Neurotransmitters. In: International Symposium on Drug Abuse and HIV/AIDS. International Symposium on Drug Abuse and HIV/AIDS. Kovalam, India; 2006.
. Co-morbidity of HIV Associated renal disease and HIV dementia complex: Implications for mechanisms of pathogenesis and clinical management. In: Journal of NeuroVirology. Vol. 9. S3th ed. Journal of NeuroVirology. ; 2003. p. 106.
. Comparing the accuracy of neuropsychological testing methods in determining neurocognitive impairment in HIV-infected Spanish speaking adults. In: UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. Los Angeles, CA; 2010.
. COMT val168met polymorphism confers risk for working memory impairment in HIV. In: Third Meeting on HIV Infection and the Central Nervous System. Third Meeting on HIV Infection and the Central Nervous System. Stresa, Italy; 2009.
. Coronary Artery Disease in HIV-Infected Patients. In: Duke University School of Medicine Alpha Omega Alpha Day. Duke University School of Medicine Alpha Omega Alpha Day. Durham, NC; 2007.
. Coronary Atherosclerosis in HIV-Infected Patients. In: 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Sydney, Australia; 2007.
. Cross-section effects of APOE E4 by Discrete Neurocognitive Domain. In: 40th Annual Conference of the International Neuropsychological Society. 40th Annual Conference of the International Neuropsychological Society. ; 2012.
. Cross-sectional and longitudinal studies of medication adherence and cognition among HIV+ adults. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Diagnosis of HIV– associated distal symmetrical polyneuropathy in the primary care setting. In: Journal of NeuroVirology. Vol. 9. S3th ed. Journal of NeuroVirology. ; 2003. pp. 105-106.
. Discovering brain mechanisms and the rules of molecular biology. In: 6th World Multiconference on Systemics, Cybernetics and Informatics. 6th World Multiconference on Systemics, Cybernetics and Informatics. Orlando, FL; 2002.
. Dopamine Depletion in Different Brain Regions of HIV-1 infected individuals: Impact on Neurocognitive Performance. In: 11th International Symposium on NeuroVirology. 11th International Symposium on NeuroVirology. New York, NY; 2012.
. Dopamine-related genes affect cognitive functioning and risk for HIV-associated neurocognitive disorders. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Drug Abuse and AIDS Brain: Unexpected expression of neuronal Nitric Oxide Synthase, Interferon Gamma, TNF-alpha, and Il-4. In: College of Problems in Drug Dependence. College of Problems in Drug Dependence. Scottsdale, AZ; 2001.
. Dysfunctional regulation of brain-derived neurotrophic factor in Human Immunodeficiency Virus-1 infected brains. In: Society for Neuroscience Annual Meeting. Society for Neuroscience Annual Meeting. Washington, D.C.; 2011.
. Education stratification based on education versus reading ability: a comparison of diagnostic accuracy of neurocognitive impairment in HIV. In: Western Student Medical Research Forum (WSMRF). Western Student Medical Research Forum (WSMRF). Carmel, CA; 2006.
. Elevated Ferritin Heavy Chain and dysregulated CXCL12/CXCR4 signaling within cortical neurons of drug abusers and HIV+ individuals. In: 11th International Symposium on NeuroVirology. 11th International Symposium on NeuroVirology. New York City; 2012.
. Ethnic Differences in Risk for HIV-associated Neuropsychological Impairment: Role of Depression and Low Literacy. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. Boston, MA; 2006.
. Ethnicity and Risk for HIV-Associated Neurocognitive Disorders. In: HIV Research: The Next Generation Conference. HIV Research: The Next Generation Conference. Los Angeles, CA; 2007.
. Executive dysfunction in AIDS patients co-infected with hepatitis C. In: Journal of the International Neuropsychological Society. Vol. 9. S2th ed. Journal of the International Neuropsychological Society. ; 2003. p. 287.
. Expression of the E2F1 transcriptional targets, Cdc2 and PUMA, in primary neurons treated with HIV-gp120 and in the brain of HIV/HAD patients. In: 7th Intl. Symposium on NeuroVirology. 7th Intl. Symposium on NeuroVirology. Philadelphia, PA; 2006.
.